Madrigal Pharmaceuticals (MDGL) EBITDA (2010 - 2026)
Madrigal Pharmaceuticals' EBITDA came in at $56.86 million for Q3 2026, compared with -$113.29 million a year earlier.
Powered by 
Analysis
Madrigal Pharmaceuticals (MDGL) EBITDA (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Madrigal Pharmaceuticals reported EBITDA of -$149.24 million; for FY2025, it came in at -$296.99 million.
- Going back by year, EBITDA was -$494.69 million in FY2024, -$377.56 million in FY2023, -$292.31 million in FY2022 and -$242.08 million in FY2021.
- The Q3 2026 figure represents the highest quarterly EBITDA in data going back to Q3 2010.
- Business Quant data shows MDGL's EBITDA at -$55.46 million (Q2 2026), -$91.89 million (Q1 2026) and -$58.75 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 13.33 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 7.37 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Madrigal Pharmaceuticals | 12.86 Bn | 9.26 Bn | - | 56.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 56.86 Mn |
| Jun 30, 2026 | -55.46 Mn |
| Mar 31, 2026 | -91.89 Mn |
| Dec 31, 2025 | -58.75 Mn |
| Sep 30, 2025 | -113.29 Mn |
| Jun 30, 2025 | -46.45 Mn |
| Mar 31, 2025 | -78.50 Mn |
| Dec 31, 2024 | -66.15 Mn |
| Sep 30, 2024 | -115.53 Mn |
| Jun 30, 2024 | -161.80 Mn |
| Mar 31, 2024 | -151.21 Mn |
| Dec 31, 2023 | -116.28 Mn |
| Sep 30, 2023 | -97.73 Mn |
| Jun 30, 2023 | -85.77 Mn |
| Mar 31, 2023 | -77.78 Mn |
| Dec 31, 2022 | -84.86 Mn |
| Sep 30, 2022 | -79.98 Mn |
| Jun 30, 2022 | -69.99 Mn |
| Mar 31, 2022 | -57.48 Mn |
| Dec 31, 2021 | -64.50 Mn |
API Access
Madrigal Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=MDGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "MDGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=MDGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();